Navigation Links
Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
Date:5/20/2009

LAMBERTVILLE, N.J., May 20 /PRNewswire/ -- Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, analyzed trends shaping future sales force models and outlined actionable training strategies to address these new models at the 38th Annual Society of Pharmaceutical and Biotech Trainers (SPBT) Conference, held May 11-14 in Chicago.

In an address titled "Sales Force of the Future," consultants Denise Woltemath and Manny Gaspar assessed four potential new sales models that may occur in the rapidly changing pharmaceutical and biotechnology environment. The team examined selling scenarios where (1) specialty representatives become the dominant sales force type, (2) a split develops between clinical representatives and service representatives, (3) the district manager evolves into a market manager and (4) targeted deployment becomes the standard practice, i.e. companies segment and target physicians according to their information delivery preferences.

The Health Strategies Group consultants shared insights with workshop participants on how to identify emerging sales force trends within their own organizations and discussed possible training plans and requirements for each of the four sales models presented.

"We were pleased to be invited to share and discuss our training ideas and analysis with the industry leaders at the SPBT annual conference," said Gaspar. "We received a lot of positive feedback from our workshop participants, many commented they had learned several methods they can implement now to navigate the changing pharmaceutical environment. We value our longstanding relationship with SPBT and are always grateful for the opportunity to collaborate with their members."

For a summary of Health Strategies Group's SPBT presentation, "Sales Force of the Future," contact info@healthstrategies.com.

About the Speakers

Denise Woltemath is a senior consultant with Health Strategies Group, leading the Specialty Sales Opportunity Assessment Service for specialty and biotechnology clients. She has more than 20 years of healthcare experience and has held leadership roles in pharmaceutical sales, managed care, medical devices and hospital settings. Woltemath's achievements include development of a training initiative that doubled the length of sales calls, management of a systematic approach to extending the impact of promotional education programs, and creation of a company-wide framework for opinion leader development.

Manny Gaspar is a consultant with Health Strategies Group and is responsible for syndicated and client private projects within the company's Strategic Selling Outlook practice. His professional experience spans the healthcare marketing spectrum, including work in analytics, sales, and product management in both the pharmaceutical and medical device industries.

About Health Strategies Group

Health Strategies Group has been providing market intelligence to pharmaceutical and biotechnology professionals since 1992, transforming research findings into practical insights and strategic recommendations to help organizations make the best business decisions. The company has long-standing relationships with 90 percent of the nation's leading pharmaceutical and biotechnology companies.

Health Strategies Group services include syndicated research reports in different practice areas, proprietary intelligence projects on request, and direct, continuous access to a team of research directors and practice leaders who are experienced veterans of the pharmaceutical industry and active thought leaders in their areas of expertise. The company also creates a custom webpage for each client that provides ready access to all pertinent publications and research summaries.

Organizations use Health Strategies Group to assess marketplace trends and future scenarios, support business planning, formulate successful segmentation strategies, guide the design of training curricula, educate colleagues, benchmark staff performance, and develop more profitable contracting strategies.

For additional information on Health Strategies Group, contact Karen Vandeven, director of marketing and communications, at (609) 397-5282 or kvandeven@healthstrategies.com. Health Strategies Group is headquartered in Lambertville, N.J., with regional offices in Redwood City, Carlsbad and Irvine, Calif. Visit the company's Web site at www.HealthStrategies.com.

    CONTACT: Bridget Calafell Wood               Cynthia Amorese
             (212) 286-2424                      (908) 665-8072
             Email: bcalafell@julielaitin.com    Email: camorese@comcast.net


'/>"/>
SOURCE Health Strategies Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):